Terry Dagnon, Chief Operating Officer at Outlook Therapeutics, Inc. (OTLK), bought 10,000 shares at $1.05 ($11K) on 2022-06-21, disclosed to the SEC on 2022-06-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OTLK | BUY | 2021-12-03 | $14K | — | Filing → |
| OTLK | SELL | 2021-02-25 | $33K | — | Filing → |
| OTLK | SELL | 2021-02-17 | $162K | — | Filing → |